The nation of Zimbabwe has declined a significant US health deal valued at 367 million US dollars (272 million pounds) over five years over the United States' insistence on confidential biological samples.
This rejection came to light following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
A government spokesperson later explained that the United States was seeking biological samples for scientific study and commercial gain but was not willing to share the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate process of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for more negotiations to secure a agreement acceptable to both sides so the nation's critical HIV treatment initiative can proceed.
Wider Implications
This development follows a similar case in Kenya, where a high court halted a similar deal with the US after legal challenges were raised about the safety of citizens' health data.
Since resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral agreements to boost openness and accountability.
Based on statements, Sixteen nations in Africa have so far signed these new agreements, representing more than $18.3bn in new funding.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation might have yielded significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment through American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"In essence, our country would provide the basic resources for medical research with no assurance that the resulting innovations would be accessible to our people if a new disease outbreak arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its push of bilateral deals were upending systems already set up via the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This system is designed to ensure that when a country provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."
These objections over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome continued discussions with our US partners on how subsequent collaboration might be structured in a manner that honours the independence and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that negotiations should continue since much of the country's HIV programmes depended on foreign aid.
"If specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group said.
The halted deal underscores the continuing debate between receiving much-needed international aid and protecting local interests in an ever more interconnected world.